Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind study of nanoquinone (Coenzyme Q10 nanodispersion) versus placebo in chronic tinnitus with low Q10
2008-002369-29Phase 2Active
- Sponsor
- MSE Pharmazeutika
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in tinnitus comparing nanoQ10 (ubidecarenone nanodispersion) with Placebo (2 arms). Primary endpoint: Change in Tinnitus Questionnaire total score. Started Jan 2009; status: active.
02
Drugs
coenzyme q10
03
Conditions
tinnitus
Beyond the preview
Go deeper on 2008-002369-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002369-29.